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Background. Many elderly persons report that they have difficulties learning new things and remembering names,
plans, and conversations. Because decreased cognitive function in elderly persons is potentially related to their poor
nutritional status, provision of essential nutrients may improve cognitive function. The authors wanted to determine
whether consumption of an enriched drink, including moderate doses of all essential micronutrients, improves cognitive
function in frail elderly persons.
Methods. Frail, white adults (n ¼ 101) who were aged 65 years or older with a body mass index 25 kg/m2 were
selected for this randomized, double-blind, placebo-controlled trial. They received either an enriched drink or a placebo
product for 6 months. Before and after the intervention, participants’ cognitive function was assessed (word learning test
[WLT], WLT delayed, category fluency [CF] for animals and professions, and recognition memory test for words
[RMTW]) and blood biochemical analyses (vitamin B12, homocysteine) were performed.
Results. Sixty-seven residents completed the study period. After 6 months, significant differences were noted in
changes of the WLT (0.9 6 0.3 vs0.1 6 0.3; p¼ .014) and CF professions (1.2 6 0.7 vs0.6 6 0.5; p¼ .017) in the
supplement group (n¼ 34) compared with the placebo group (n¼ 33). No significant differences were observed in WLT
delayed, RMTW, and CF animals. The plasma vitamin B12 concentration increased (105 6 50 vs 8 6 16; p¼ .003) and
the homocysteine concentration decreased (–6.3 6 5.9 vs0.3 6 2.9; p¼ .000) in the supplement group compared with
the placebo group.
Conclusions. This study contributes to the evidence that nutritional supplementation may improve neuropsychological
performance in frail elderly persons.
MANY elderly persons indicate that their abilities tolearn new things (68%) and to remember names
(54%), plans (48%), and conversations (35%) have de-
creased with aging (1). It is estimated that 22% of the
community-dwelling elderly is cognitively impaired, and
this proportion increases with age (2). Several studies have
found that older adults’ performances on a variety of psy-
chometric tests decline over time [reviewed by Storandt (3)].
Specifically, declarative memory, a domain of memory
associated with conscious recollection and usually assessed
with recall or recognition tests, is consistently impaired in
elderly persons (4).
Many causes of cognitive impairment exist in elderly
persons (2), and impaired nutritional status has been noted
as one of them (5). Through epidemiologic studies, the
presence of an association between nutrition and cognitive
function has become more clear (6,7). These investigations
have shown that low intake of nutrients such as thiamin,
vitamin B6, vitamin B12, folate (8–12), antioxidants (10,13–
15), and specific fatty acids (16) are related to decreased
cognitive function.
Low food intake is prevalent in certain groups of elderly
persons, with the highest prevalence in elderly persons living
in institutions (17). This results in a prevalence of inadequate
intake of vitamins B1, B2, B6, and C of 61%, 31%, 58%, and
18%, respectively (17), confirmed by suboptimal biochem-
ical concentrations.
A few supplementation studies focused on improved
cognitive function have been performed. Some of these had
no placebo treatment (18) or included participants who
already had clinical symptoms of cognitive impairment
(19–22) or biochemical deficiencies (21,23,24). Only a few
studies have been performed in healthy, community-
dwelling elderly persons, and the results were contradictory
(25,26) or positive but only in those studies in which
megadoses of micronutrients were supplied (27–29).
Our aim was to determine, in a well-designed study,
whether use of an enriched drink including moderate doses
of micronutrients can improve cognitive function in frail
elderly persons.
METHODS
Study Design
In this randomized, double-blind, placebo-controlled trial,
participants received either an enriched drink or a placebo
product for 6 months. Before and after the intervention, we
assessed cognitive function and performed blood biochem-
ical analyses.
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Participants were randomly assigned, in groups of four
matched for body mass index (BMI), to receive either
nutritional supplementation with a 125-ml enriched drink
(containing 30%–150% of the U.S. Recommended Daily
Allowance of vitamins and minerals, with enhanced amounts
of antioxidants, and containing 250 kcal energy in a daily
dose; Table 1) or a noncaloric placebo twice daily between
main meals. Participants were randomly assigned to receive
either a supplement or a placebo by an independent per-
son not involved in the study. To maximize compliance,
participants were visited in their homes every 2 weeks. At
that time, they were given additional supplements and any
unused packages were counted. Compliance percentages were
quantified according to this equation: (number of supple-
ments provided–number of supplements returned) / (number
of days participation in study 3 2)3 100%. All tests were
administered by the same trained investigator before and
after 6 months of supplementation.
Participants
We selected frail white persons aged 65 years or older who
had a BMI less than 25 kg/m2 and resided in a home for
elderly persons or sheltered housing residence. Residents
with cancer, gastrointestinal disease, need for a therapeutic
diet incompatible with supplementation, or mental inability
to respond to study questions or to remember taking the
supplement were not eligible to participate. Participants were
enrolled between May 1999 and March 2001. The medical
ethics committee of Wageningen University, The Nether-
lands, approved the study. Participants gave written in-
formed consent before randomization.
Participant characteristics.—Age, sex, education, the
number of prescribed medicines, diagnosed chronic diseases,
and visual impairment were recorded.
Dietary intake.—A 3-day estimated dietary record was
collected (30). We calculated food intake using standard
portion sizes using the computerized 1997 Dutch Food
Composition Table (31).
Blood sampling.—Venous blood samples were collected in
the participants’ homes in coagulation tubes (vitamin B12) or
heparin-prepared tubes (homocysteine) at baseline and at the
end of the study. The participants had fasted overnight and
were in a sitting position. Samples were cooled immediately
and centrifugedwithin 4 hours at 2500g for 10minutes at 48C.
Plasma (homocysteine) or serum (vitamin B12) was removed
and stored at808C for batch analysis at the end of the study.
Biochemical measurements.—Plasma homocysteine was
measured using high-powered liquid chromatography ac-
cording to the method of Daskalakis and coworkers (32).
Serum vitamin B12 was analyzed for a selected group of 26
participants, for whom leftover serum samples were avail-
able, using ion capture Imx (Abbott Laboratories, Abbott
Park, IL) (33). Concentrations greater than 221 pmol/l were
considered normal (34). Analyses were performed at the
Department of Clinical Chemistry, University Medical
Center St. Radboud, Nijmegen (vitamin B12) and the
Department of Analytical Chemistry, Numico Research,
Wageningen, The Netherlands (homocysteine).
Anthropometric measurements.—Anthropometric meas-
urements were performed with participants wearing light
clothing without shoes and after emptying their bladders.
Body weight was measured to the nearest 0.1 kg using
a calibrated scale (Seca, Hamburg, Germany). Knee height
was measured to the nearest 0.1 cm using a stadiometer to
estimate participant height. Body mass index was calculated
as weight / (knee height23 10) (35).
Mini-Mental State Examination (MMSE).—The Mini-
Mental State Examination was performed according to the
method of Folstein and colleagues (36). A maximum score of
30 points for persons in good mental state can be achieved
(37), and a cutoff score of 23 was used to define cognitive
impairment (38). The version including the serial sevens
form was selected (39).
Geriatric Depression Scale.—The short version of the
geriatric depression scale for affective capacity was applied
Table 1. Composition of the Dietary Supplement per Daily Dose
(250 ml)
Nutrient Amount
Energy (MJ) (kcal) 1.05 (250)
Protein (whey) (g) 8.75 (14% energy)
Carbohydrates (g) 28.5 (46% energy)
Fat (g) 11.25 (40% energy)
Dietary fiber (g) 4.5
Sodium (mg) 80
Potassium (mg) 550
Chloride (mg) 40
Calcium (mg) 400
Phosphorus (mg) 400
Magnesium (mg) 100
Iron (mg) 9
Zinc (mg) 18
Copper (mg) 3
Manganese (mg) 4
Fluoride (lg) 75
Molybdenum (lg) 40
Selenium (lg) 85
Chromium (lg) 35
Iodine (lg) 150
Vitamin A (lg) 240
Carotenoids (mg) 3
Vitamin D (lg) 13
Vitamin E (mg) 70
Vitamin K (lg) 80
Vitamin C (mg) 250
Vitamin B1 (mg) 1.9
Vitamin B2 (mg) 1.9
Vitamin B6 (mg) 2.5
Vitamin B12 (lg) 5.3
Niacin (mg NE) 14
Pantothenic acid (mg) 4.5
Folate (lg) 480
Biotin (lg) 70
Coenzyme Q10 (mg) 3
Flavonoids (mg) 19
Note: Placebo contains no energy, vitamins, or minerals.
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(40,41). Participants were classified as depressed if they had
a score of 5 or more.
Neuropsychological Tests
Word learning test (WLT).—The Dutch version of the 15-
word learning test was administered (Department of
Neuropsychology, University of Groningen, The Nether-
lands). Fifteen words were read to the participants, who were
then asked to repeat as many words as possible (immediate
recall). This was repeated five times, and then delayed recall
(WLT delayed) was tested after the participants performed
nonstrenuous, non-neuropsychological tests for 10 minutes.
The total number of correct words of the five repetitions was
summed and divided by the number of repetitions (for
a maximum score of 15). Delayed recall was scored as the
total number of correct words (for maximum score of 15).
Category fluency (CF) test.—Two category fluency tests
were administered in which the participants were asked to
name, within 60 seconds, as many animals or professions as
they could (42,43).
Recognition memory test for words (RMTW).—The Dutch
version of the RMTW, as described by Diesfeldt (44), was
used. After hearing 50 words, each spaced by 3 seconds, the
participants were asked to recognize the words from 50 pairs
including a correct word and a distractor (for a maximum
score of 50).
Statistical Analyses
Values mentioned are means 6 standard deviations for
descriptives and means 6 standard error of the mean for
changes. We compared the characteristics and baseline
neuropsychological scores of the supplement and control
groups using the two-sided Student t test, chi-squared test,
and the Wilcoxon signed rank test (if not normally
distributed according to the Kolmogorov Smirnov test:
WLT delayed, CF animals). We compared the changes in
neuropsychological scores in both trial groups using the one-
sided Student t test, because we hypothesized improved
cognitive function in the supplement group. We performed
post hoc tests using paired t tests. Probability values less than
.05 were considered significant. We calculated effect size
(ES) as the mean change/standard deviation (45). We
analyzed the data using SPSS version 10.0 for Windows
(SPSS, Chicago, IL).
RESULTS
Baseline Characteristics and Study Compliance
One hundred one residents were randomized, of whom 34
dropped out during the study period. Figure 1 shows
a participant flow chart. Intention-to-treat analyses of the
101 residents using last observation carried forward analysis
for outcome variables did not differ from analyses of
participants who completed the study. Data reported are thus
from residents for whom complete data for the study period
were obtained. Baseline characteristics were similar in the
group that completed the study period and the group that
dropped out, except for the MMSE scores, which were
significantly less in the participants who dropped out. High
compliance was observed for the supplement group (88% 6
23%) and for the placebo group (94% 6 14%).
Table 2 reports baseline characteristics, of which none was
significantly different. Twenty-three percent of participants
had a score of 23 or less on the MMSE. Sixteen percent had
a score higher than 5 on the Geriatric Depression Scale. The
proportions of participants with a vitamin intake less than two
thirds of the U.S. Recommended Daily Allowance (2001)
(46) were 36% for vitamin B1, 11% for vitamin B2, 53% for
vitamin B6, 10% for vitamin B12, and 15% for folate.
Neuropsychological Tests
Table 3 shows the neuropsychological scores at baseline
and follow-up. Scores for the WLT (ES ¼ 0.43) and CF
professions (ES ¼ 0.44) improved significantly during the
study period in the supplement group (n¼34) compared with
the placebo group (n ¼ 33). We found no significant dif-
ferences for changes between groups in WLT delayed (ES¼
0.20), RMTW (ES¼0.39), and CF animals (ES¼ 0). The
supplement group had significantly lower baseline WLT and
WLT delayed scores. Paired t tests indicated a significant
increase in scores in the supplement group for WLT, WLT
delayed, CF professions, and CF animals but not for RMTW.
No significant changes occurred in the placebo group.
Plasma Vitamin B12 and Homocysteine
We found a significant increase in vitamin B12 concen-
tration and a decrease in homocysteine concentration in the
supplement group during the study period. Concentra-
tions remained similar in the placebo group. This resulted
Table 2. Baseline Parameters of Frail Elderly Participants in the
Supplementation Study (Means 6 SD)
Parameter Placebo Supplement
N 33 34
Age (y) 81 6 7 84 6 6
Female (%) 53 62
BMI (kg/m2) 24.1 6 2.3 23.5 6 2.4
Energy intake (kJ/d)* 6818 6 1210 7133 6 1636
Energy intake (kcal/d) 1623 6 289 1700 6 392
Intake of vitamin B1 (mg/d)* 0.94 6 0.77 1.04 6 0.94
Intake of vitamin B2 (mg/d)* 1.23 6 0.37 1.19 6 0.35
Intake of vitamin B6 (mg/d)* 1.13 6 0.28 1.11 6 0.33
Intake of vitamin B12 (lg/d)* 3.59 6 1.50 3.71 6 2.35
Intake of folate (lg/d)* 203 6 52.7 182 6 61.2
GDS .5 (%) 3.7 6 2.5 (21) 3.3 6 2.4 (12)
MMSE 23 (%) 26 6 3 (21) 26 6 3 (24)
Education (%)
6 years 38 50
7–9 years 47 35
.9 years 15 15
Impaired vision 1/33 4/34
No. of chronic diseases 1.6 6 1.1 2.0 6 1.4
No. of medications 3.6 6 2.8 4.2 6 3.7
Notes: *n ¼ 25 þ 27 for both groups.
GDS ¼ Geriatric Depression Scale; MMSE ¼ Mini-Mental State
Examination; BMI ¼ body mass index.
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in a significant difference between groups during the
study period.
DISCUSSION
We observed a significant improvement on two tests of
cognitive function (WLT and CF professions) after 6 months
of consumption of an enriched drink by frail elderly persons.
The population we selected were elderly persons living in
homes for the elderly or sheltered residences who could
respond to study questions and who would not forget to
consume the daily supplement. Although they were not
severely cognitively impaired, the presence of persons with
mild cognitive impairment or dementia cannot be excluded,
because it can be present at an early stage without being
diagnosed, which is suggested by the 23% of participants
with low MMSE scores. Potential participation of persons
with very high or very low cognitive function was relatively
low, so our pool of participants had intermediate cognitive
function. The final mean MMSE score in our study
population is comparable to scores found in the general
elderly population (mean MMSE, 26 points) (38), slightly
higher than the average found in residences for the elderly
(meanMMSE, 20) (18), elderly persons living in service flats
(mean MMSE, 23) (47), and frail elderly persons living in
their own homes (mean MMSE, 20) (48), but it was lower
than in healthy elderly persons (mean MMSE, 28–29)
(49,50). Chandra (25) observed a lower MMSE score in
persons with a plasma deficiency of one or more vitamins
compared with those who were not deficient. A significant
proportion of our participants had low intakes of vitamins,
and the average homocysteine concentration [which can be
considered an indicator of impaired status of vitamin B6,
vitamin B12, and folate (51)] in our population was greater
than in other studies of community-dwelling elderly persons
(26,34,52). This supports the assumption that our population
is at risk for subclinical deficiency and therefore could
benefit from vitamin supplementation.
Because plasma homocysteine concentrations are related
to cognitive function (53,54), we measured changes in
homocysteine levels as a biochemical variable in addition to
the cognitive tests. Indeed, besides the improvement in
cognitive tests we found a significant decrease in plasma
homocysteine concentrations. Our data support the efficacy
of relatively low-dose oral micronutrient supplementation
for decreasing homocysteine concentrations in elderly
persons, as found in previous studies in other groups of
elderly persons (26,55). However, changes in antioxidant
levels may also have contributed to the improvements we
found in the participants’ neuropsychological test scores.
The tests we used were representative of the typical areas
of cognitive decline in elderly persons (1,56,57). Verbal
fluency reflects frontal lobe and language function (58), and
studies have suggested that vitamin B12 deficiency may be
associated with frontal lobe damage (59). Antioxidant levels
appear to be related to the same tests of semantic memory,
free recall, and recognition (15). Previous supplementation
studies showed that the tests we used were sensitive to
improvements (24).
We used the same test versions at both measurement
times, because we did not expect the presence of a learning
effect after such a long time. Furthermore, the study was
placebo controlled. Paired analysis in the placebo group
indeed showed no significant changes during the study
period for any of the neuropsychological tests. This
corresponds with observations by Chandra (25) during a
1-year period.
The score on the WLT is a measure of short-term memory,
and the delayed score is a measure of intermediate memory
(60). The absolute scores on the WLT in our population were
much lower than in healthy elderly persons with a mean age
of 81 years (61). The effect sizes we found on the WLT
and CF professions can be considered small to medium
according to the classification of Cohen (45). This means that
the results are, from a statistical perspective, substantial and
indicate possible clinical relevance.
The fact that the participants’ baseline scores on two of
the neuropsychological tests were not well matched for our
groups may affect the interpretation of our results. However,
Table 3. Mean Scores on Memory Tests at Baseline and Changes After 6 Months of Nutritional Supplementation in Frail Elderly Persons
Receiving Placebo (n ¼ 33) or Supplement (n ¼ 34)
Test
Baseline (Mean 6 SD) Change (Mean 6 SEM)
p 95% CIPlacebo Supplement Placebo Supplement
Neuropsychological tests
WLT 6.1 6 2.2 4.4 6 2.1* 0.1 6 0.3 0.9 6 0.3 0.014 1.71
WLT delayedy 6.6 6 2.1 4.7 6 2.8* 0.3 6 0.4 0.9 6 0.4 0.152 1.85
RMTWz 40.9 6 5.5 40.3 6 4.9 0.7 6 1.2 1.1 6 0.9 0.383 1.19
Category fluency animals 15.2 6 4.3 13.9 6 4.5 0.9 6 0.7 0.9 6 0.6 0.473 1.88
Category fluency professions 11.9 6 3.4 10.1 6 4.3 0.6 6 0.5 1.2 6 0.7 0.017 3.46
Biochemistry
Plasma homocysteine (lmol/L)§ 17.6 6 5.0 18.4 6 7.9 0.3 6 2.9 6.3 6 5.9 0.000 —
Plasma vitamin B12 (pmol/L)jj 290 6 99 304 6 118 8 6 16 105 6 50 0.003 —
Notes: * p , .01 versus placebo.
y n ¼ 27 for both groups.
z n ¼ 30 for placebo; n ¼ 28 for supplement.
§ n ¼ 23 for placebo; n ¼ 2 for supplement, nonparametric test.
jj n ¼ 14 for placebo; n ¼ 12 for supplement, nonparametric test.
WLT¼Word learning test; RMTW ¼ recognition memory test for words.
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scores in the placebo group were not as high to preclude
improvement; rather, the lower scores in the supplement
group may have risked to preclude improvement. Subtle
changes in cognitive function can be difficult to measure,
because more severely affected persons probably will not
have improvement on neuropsychological tests. A possible
explanation for this could be that restoration of the
transmethylation capacity with increased synthesis of neuro-
transmitters could contribute to the beneficial effect of
vitamin substitution. Persons with mild to moderate de-
mentia may have better preserved neuronal function and are
more likely to respond clinically to vitamin substitution than
would persons with severe dementia (21). As also indicated
by the MMSE scores, we did not include such a severely
impaired group, and the scores in the supplement group did
increase during the study period. Chandra (25) observed that
those persons whose baseline plasma values were low and
responded to supplementation had a greater improvement in
cognition. This may have been the case for our supplement
group, in whom we found low plasma concentrations of
several vitamins.
This study contributes to the evidence that nutritional
supplementation may improve neuropsychological perfor-
mance in frail elderly persons. From the effect sizes we
obtained we may infer that our results are clinically relevant.
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